Keywords: AstraZeneca, Brilinta, USA, FDA, Blood thinner, ACS, Heart attack

US FDA at last approves AstraZeneca blood-thinning drug Brilinta

Article | 21 July 2011

Print This

There was much awaited good news for Anglo-Swedish drug major AstraZeneca (LSE: AZN) last night, when the US Food and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in